Broker’s Call: Piramal Pharma (Buy)
Target: 114 rupees CMP: INR 72.42 In the third quarter and the first nine months of fiscal ’23, the company
Continue readingThe Number One Finance & Business Blog!
Target: 114 rupees CMP: INR 72.42 In the third quarter and the first nine months of fiscal ’23, the company
Continue readingDomestic benchmarks opened lower on Wednesday amid weak global signals Debt ceiling negotiations in the United Stateswhile analysts expect investors
Continue readingAsian stocks fell on Wednesday and the dollar hovered around a five-week peak as investors remained risk averse, with US
Continue readingTata consumer products On Tuesday, it said it would remove global depository receipts (GDRs) from the London Stock Exchange and
Continue readingAirtel reported results for Q4 that can be viewed as generally included to positive. While revenue missed the consensus (Bloomberg)
Continue readingGlobal stocks were flat on Tuesday, while the dollar retreated from a five-week high ahead of another round of talks
Continue readingA year after entering the market with an extension initial public offering (IPO)Arrow Life Insurance Corporation (LIC) It is trading
Continue readingThe Board of Directors of Eiko LifeSciences has approved the issuance of 55,44,178 partially paid shares at par value of
Continue readingShare prices of several Karnataka-based companies like Infosys, Mphasis, BEML and Biocon, among others, have seen a boom in today’s
Continue readingThe National Stock Exchange (NSE) on Monday reported a 31 per cent rise in consolidated net profit of INR 2,067
Continue reading